Issue 22, 2026, Issue in Progress

DNA aptamers that inhibit binding to human interleukin-17A and interleukin-20

Abstract

Cytokines interleukin-17 (IL-17) and interleukin-20 (IL-20) play important roles in inflammatory processes and autoimmune diseases. Using systematic evolution of ligands by exponential enrichment (SELEX), we have isolated DNA aptamers for each of these cytokines. For IL-17A, the best aptamers bound with Kd values as low as 4 nM, comparable to previously reported aptamers. IL-20 represents a novel target for aptamer identification and SELEX isolated aptamers with Kd values as low as 120 nM. Photo-crosslinking experiments confirmed aptamer binding to its cytokine target, most likely to the cytokine monomer. These novel DNA aptamers for IL-17 and IL-20 represent valuable tools for studying cytokine biology and developing potential therapeutics for inflammatory and autoimmune conditions like psoriasis and impaired wound healing.

Graphical abstract: DNA aptamers that inhibit binding to human interleukin-17A and interleukin-20

Supplementary files

Article information

Article type
Paper
Submitted
08 Jan 2026
Accepted
08 Apr 2026
First published
20 Apr 2026
This article is Open Access
Creative Commons BY license

RSC Adv., 2026,16, 20340-20346

DNA aptamers that inhibit binding to human interleukin-17A and interleukin-20

A. Parvez, K. Sully and D. A. Baum, RSC Adv., 2026, 16, 20340 DOI: 10.1039/D6RA00178E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements